Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam P Dicker

Showing results (211-220 of 286) with videos related to

Pageof 29
Sort By:
Journal of Cellular Physiology|January 30, 2013
β1 integrins mediate resistance to ionizing radiation in vivo by inhibiting c-Jun amino terminal kinase 1Hira Lal Goel, Aejaz Sayeed, Michael Breen, et al.
Brachytherapy|June 24, 2014
Large prostate gland size is not a contraindication to low-dose-rate brachytherapy for prostate adenocarcinomaKosj Yamoah, Harriet B Eldredge-Hindy, Nicholas G Zaorsky, et al.
International Journal of Radiation Oncology, Biology, Physics|June 13, 2012
A phase I study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and recurrent high-grade gliomasRobert B Den, Mitchell Kamrava, Zhi Sheng, et al.
Journal of Cancer Metastasis and Treatment|November 18, 2021
Development of a Functional Assessment of Chronic Illness Therapy item library and primary symptom list for the assessment of patient-reported adverse events associated with immune checkpoint modulatorsKimberly A Webster, Mary L O'Connor, Aaron R Hansen, et al.
Cancer|October 21, 2017
Expression of the DNA repair gene MLH1 correlates with survival in patients who have resected pancreatic cancer and have received adjuvant chemoradiation: NRG Oncology RTOG Study 9704Yaacov R Lawrence, Jennifer Moughan, Anthony M Magliocco, et al.
International Journal of Radiation Oncology, Biology, Physics|November 28, 2012
RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patientsArnab Chakravarti, Meihua Wang, H Ian Robins, et al.
Cancers|March 28, 2026
A Mitochondrial Plasma Proteomic Signature Identifies Metastatic Chromophobe Renal Cell CarcinomaClara Steiner, Tiegang Han, Steven Safi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2015
Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate CancerKosj Yamoah, Michael H Johnson, Voleak Choeurng, et al.
Plos One|April 16, 2014
The KRAS-variant and miRNA expression in RTOG endometrial cancer clinical trials 9708 and 9905Larissa J Lee, Elena Ratner, Mohamed Uduman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 29, 2016
Reaffirming and Clarifying the American Society of Clinical Oncology's Policy Statement on the Critical Role of Phase I Trials in Cancer Research and TreatmentJeffrey S Weber, Laura A Levit, Peter C Adamson, et al.
Pageof 29

Showing results (211-220 of 286) with videos related to

Sort By:
Pageof 29
Journal of Cellular Physiology|January 30, 2013
β1 integrins mediate resistance to ionizing radiation in vivo by inhibiting c-Jun amino terminal kinase 1Hira Lal Goel, Aejaz Sayeed, Michael Breen, et al.
Brachytherapy|June 24, 2014
Large prostate gland size is not a contraindication to low-dose-rate brachytherapy for prostate adenocarcinomaKosj Yamoah, Harriet B Eldredge-Hindy, Nicholas G Zaorsky, et al.
International Journal of Radiation Oncology, Biology, Physics|June 13, 2012
A phase I study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and recurrent high-grade gliomasRobert B Den, Mitchell Kamrava, Zhi Sheng, et al.
Journal of Cancer Metastasis and Treatment|November 18, 2021
Development of a Functional Assessment of Chronic Illness Therapy item library and primary symptom list for the assessment of patient-reported adverse events associated with immune checkpoint modulatorsKimberly A Webster, Mary L O'Connor, Aaron R Hansen, et al.
Cancer|October 21, 2017
Expression of the DNA repair gene MLH1 correlates with survival in patients who have resected pancreatic cancer and have received adjuvant chemoradiation: NRG Oncology RTOG Study 9704Yaacov R Lawrence, Jennifer Moughan, Anthony M Magliocco, et al.
International Journal of Radiation Oncology, Biology, Physics|November 28, 2012
RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patientsArnab Chakravarti, Meihua Wang, H Ian Robins, et al.
Cancers|March 28, 2026
A Mitochondrial Plasma Proteomic Signature Identifies Metastatic Chromophobe Renal Cell CarcinomaClara Steiner, Tiegang Han, Steven Safi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2015
Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate CancerKosj Yamoah, Michael H Johnson, Voleak Choeurng, et al.
Plos One|April 16, 2014
The KRAS-variant and miRNA expression in RTOG endometrial cancer clinical trials 9708 and 9905Larissa J Lee, Elena Ratner, Mohamed Uduman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 29, 2016
Reaffirming and Clarifying the American Society of Clinical Oncology's Policy Statement on the Critical Role of Phase I Trials in Cancer Research and TreatmentJeffrey S Weber, Laura A Levit, Peter C Adamson, et al.
Pageof 29